These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3235653)

  • 1. Enzyme-linked immunosorbent assay to evaluate the immunogenicity of a polyvalent Klebsiella capsular polysaccharide vaccine in humans.
    Granström M; Wretlind B; Markman B; Cryz S
    J Clin Microbiol; 1988 Nov; 26(11):2257-61. PubMed ID: 3235653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human IgG and IgA subclass response following immunization with a polyvalent Klebsiella capsular polysaccharide vaccine.
    Cryz SJ; Cross AS; Sadoff GC; Que JU
    Eur J Immunol; 1988 Dec; 18(12):2073-5. PubMed ID: 3220104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and immunogenicity of Klebsiella pneumoniae K1 capsular polysaccharide vaccine in humans.
    Cryz SJ; Fürer E; Germanier R
    J Infect Dis; 1985 Apr; 151(4):665-71. PubMed ID: 3882856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and immunogenicity of a polyvalent Klebsiella capsular polysaccharide vaccine in humans.
    Cryz SJ; Mortimer P; Cross AS; Fürer E; Germanier R
    Vaccine; 1986 Mar; 4(1):15-20. PubMed ID: 3962447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum antibodies to pneumococcal C polysaccharide in children: response to acute pneumococcal otitis media or to vaccination.
    Koskela M
    Pediatr Infect Dis J; 1987 Jun; 6(6):519-26. PubMed ID: 3615065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody responses to polysaccharide and polysaccharide-conjugate vaccines after treatment of Hodgkin disease.
    Molrine DC; George S; Tarbell N; Mauch P; Diller L; Neuberg D; Shamberger RC; Anderson EL; Phillips NR; Kinsella K; Ambrosino DM
    Ann Intern Med; 1995 Dec; 123(11):828-34. PubMed ID: 7486464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoglobulin G antibody responses to polyvalent pneumococcal vaccine in children in the highlands of Papua New Guinea.
    Pomat WS; Lehmann D; Sanders RC; Lewis DJ; Wilson J; Rogers S; Dyke T; Alpers MP
    Infect Immun; 1994 May; 62(5):1848-53. PubMed ID: 8168948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a Validated Luminex-Based Multiplex Immunoassay for Measuring Immunoglobulin G Antibodies in Serum to Pneumococcal Capsular Polysaccharides.
    Tan CY; Immermann FW; Sebastian S; Pride MW; Pavliakova D; Belanger KA; Watson W; Scott DA; Sidhu M; Jansen KU; Giardina PC
    mSphere; 2018 Aug; 3(4):. PubMed ID: 30089644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial.
    MacDonald NE; Halperin SA; Law BJ; Forrest B; Danzig LE; Granoff DM
    JAMA; 1998 Nov; 280(19):1685-9. PubMed ID: 9832000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of immunoglobulin G and M antibodies to type 3 pneumococcal capsular polysaccharide by enzyme-linked immunosorbent assay.
    Carlson BA; Giebink GS; Spika JS; Gray ED
    J Clin Microbiol; 1982 Jul; 16(1):63-9. PubMed ID: 7107861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroepidemiology of Klebsiella bacteremic isolates and implications for vaccine development.
    Cryz SJ; Mortimer PM; Mansfield V; Germanier R
    J Clin Microbiol; 1986 Apr; 23(4):687-90. PubMed ID: 3517058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolating polysaccharide IgG pneumococcal antibody responses by pre-adsorption of conjugate vaccine serotypes: A modified approach for the conjugate vaccine era.
    Mohamed OE; Williams L; Wong GK; Hayes M; Townsend K; Harding S; Huissoon AP
    J Immunol Methods; 2020 Nov; 486():112846. PubMed ID: 32882318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to a heptavalent conjugate Streptococcus pneumoniae vaccine in children with recurrent infections who are unresponsive to the polysaccharide vaccine.
    Sorensen RU; Leiva LE; Giangrosso PA; Butler B; Javier FC; Sacerdote DM; Bradford N; Moore C
    Pediatr Infect Dis J; 1998 Aug; 17(8):685-91. PubMed ID: 9726341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Study of Immunogenic Properties of Purified Capsular Polysaccharides from
    Goyette-Desjardins G; Auger JP; Dolbec D; Vinogradov E; Okura M; Takamatsu D; Van Calsteren MR; Gottschalk M; Segura M
    Infect Immun; 2020 Sep; 88(10):. PubMed ID: 32747605
    [No Abstract]   [Full Text] [Related]  

  • 15. Detection of immunoglobulin G to Pasteurella haemolytica capsular polysaccharide by enzyme-linked immunosorbent assay.
    Townsend EL; Maheswaran SK; Leininger JR; Ames TR
    J Clin Microbiol; 1987 Feb; 25(2):242-7. PubMed ID: 3818920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An enzyme-linked immunosorbent assay suitable for the routine estimation of specific immunoglobulin G responses to polyvalent pneumococcal polysaccharide vaccine in humans.
    Nieuwhof WN; Hodgen AN
    J Immunol Methods; 1985 Nov; 84(1-2):197-202. PubMed ID: 4067315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Capsular polysaccharide conjugate vaccines against contagious bovine pleuropneumonia: Immune responses and protection in mice.
    Waite ER; March JB
    J Comp Pathol; 2002; 126(2-3):171-82. PubMed ID: 11945006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Validation of 13-plex Luminex-Based Assay for Measuring Human Serum Antibodies to
    Pavliakova D; Giardina PC; Moghazeh S; Sebastian S; Koster M; Pavliak V; McKeen A; French R; Jansen KU; Pride M
    mSphere; 2018 Aug; 3(4):. PubMed ID: 30089645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative determination in human sera of vaccine-induced antibody to type-specific polysaccharides of group B streptococci using an enzyme-linked immunosorbent assay.
    Eisenstein TK; De Cueninck BJ; Resavy D; Shockman GD; Carey RB; Swenson RM
    J Infect Dis; 1983 May; 147(5):847-56. PubMed ID: 6341484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CpG oligodeoxynucleotides act as adjuvants for pneumococcal polysaccharide-protein conjugate vaccines and enhance antipolysaccharide immunoglobulin G2a (IgG2a) and IgG3 antibodies.
    Chu RS; McCool T; Greenspan NS; Schreiber JR; Harding CV
    Infect Immun; 2000 Mar; 68(3):1450-6. PubMed ID: 10678959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.